Clinical Trial Update: GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1) [Phase 1]

View source ↗

Summary

Phase 1 trial update of GAD-Alum (Diamyd) injected into lymph nodes with Vitamin D in Type 1 diabetes (DIAGNODE-1) completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GAD-Alum (Diamyd) (GAD-alum)

Snippet

Sponsor: Johnny Ludvigsson | Conditions: Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2020-04-27